TOSI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.127
EU - Europa 16.592
AS - Asia 14.571
SA - Sud America 1.967
Continente sconosciuto - Info sul continente non disponibili 419
AF - Africa 346
OC - Oceania 56
Totale 65.078
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.642
GB - Regno Unito 4.582
IT - Italia 4.411
SG - Singapore 4.013
CN - Cina 3.944
SE - Svezia 3.077
HK - Hong Kong 1.881
BR - Brasile 1.472
VN - Vietnam 1.456
DE - Germania 918
BD - Bangladesh 720
RU - Federazione Russa 635
FI - Finlandia 614
TR - Turchia 603
UA - Ucraina 592
FR - Francia 544
KR - Corea 476
IN - India 381
CA - Canada 234
BG - Bulgaria 227
NL - Olanda 182
ID - Indonesia 164
AR - Argentina 155
IQ - Iraq 140
JP - Giappone 129
MX - Messico 122
ES - Italia 115
IE - Irlanda 109
ZA - Sudafrica 103
PL - Polonia 84
BE - Belgio 82
PK - Pakistan 82
EC - Ecuador 78
RO - Romania 78
CO - Colombia 77
AE - Emirati Arabi Uniti 71
LT - Lituania 65
MY - Malesia 63
VE - Venezuela 57
CH - Svizzera 53
EG - Egitto 47
IR - Iran 46
IL - Israele 45
AU - Australia 44
UZ - Uzbekistan 40
CL - Cile 39
MA - Marocco 39
PH - Filippine 36
PY - Paraguay 34
DZ - Algeria 31
TN - Tunisia 31
JO - Giordania 29
AT - Austria 28
SA - Arabia Saudita 28
CZ - Repubblica Ceca 27
GR - Grecia 26
CR - Costa Rica 24
KE - Kenya 24
NP - Nepal 24
TW - Taiwan 24
JM - Giamaica 23
PT - Portogallo 22
TH - Thailandia 22
AZ - Azerbaigian 21
KZ - Kazakistan 20
EE - Estonia 19
PE - Perù 18
UY - Uruguay 18
BO - Bolivia 17
ET - Etiopia 17
SN - Senegal 15
DK - Danimarca 14
EU - Europa 14
BY - Bielorussia 13
AL - Albania 11
DO - Repubblica Dominicana 11
HU - Ungheria 11
LB - Libano 11
NZ - Nuova Zelanda 11
OM - Oman 11
TT - Trinidad e Tobago 11
HN - Honduras 10
KG - Kirghizistan 10
PA - Panama 10
RS - Serbia 10
NO - Norvegia 9
KH - Cambogia 8
LY - Libia 8
PS - Palestinian Territory 8
HR - Croazia 7
LK - Sri Lanka 7
NI - Nicaragua 7
PR - Porto Rico 7
AM - Armenia 6
CY - Cipro 6
GE - Georgia 6
GT - Guatemala 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
BZ - Belize 5
Totale 64.569
Salva come PNG Salva come JPEG
Città #
Southend 3.452
Ashburn 2.819
Santa Clara 2.752
Singapore 2.441
Fairfield 2.223
Hong Kong 1.837
Stockholm 1.816
Chandler 1.671
Woodbridge 1.618
Chicago 1.282
Hefei 1.276
Jacksonville 1.140
San Jose 1.042
Houston 1.018
Seattle 965
Wilmington 938
Dearborn 876
Los Angeles 809
Beijing 792
Ann Arbor 776
Nyköping 761
Cambridge 752
London 610
Modena 546
Council Bluffs 513
Ho Chi Minh City 500
Seoul 405
Salt Lake City 401
Helsinki 380
The Dalles 377
New York 371
Izmir 330
Hanoi 324
Milan 311
Dallas 271
Princeton 235
Sofia 216
San Diego 204
Eugene 201
Lauterbourg 197
Rome 188
Bologna 183
Tampa 173
Buffalo 172
Moscow 169
Elk Grove Village 168
São Paulo 143
Shanghai 135
Munich 124
Redwood City 121
Orem 116
Jakarta 114
Frankfurt am Main 107
Tokyo 103
Bremen 94
Falls Church 93
Lancaster 92
Phoenix 89
Des Moines 85
Dublin 85
Fremont 84
Reggio Emilia 80
Sterling 79
Miami 75
Columbus 71
Naples 70
Chennai 69
Brussels 68
Boardman 65
Florence 64
Parma 64
Da Nang 57
Guangzhou 56
Warsaw 55
Haiphong 54
Dulles 53
Brooklyn 51
Johannesburg 51
Toronto 51
Montreal 50
Atlanta 49
Baghdad 48
Catania 46
Denver 46
Detroit 46
Nanjing 46
Amsterdam 43
Turin 43
Como 41
Rio de Janeiro 41
Bari 40
Palermo 40
Washington 40
Tulare 39
Norwalk 38
Mexico City 37
Mumbai 37
Napoli 37
Manchester 36
Miano 34
Totale 44.096
Salva come PNG Salva come JPEG
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.041
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 597
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 512
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 496
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 478
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 467
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 464
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 459
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 449
PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid 437
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 433
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 423
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 421
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 421
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 419
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 417
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 408
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 405
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 400
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 399
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 397
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 394
Chemo-enzymatic synthesis of levodropropizine 389
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 388
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 386
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 385
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 380
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 380
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 376
Polymeric nanoparticles for the drug delivery to the central nervous system 375
Nanoparticle transport across the blood brain barrier 370
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 370
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 369
Vegetable cells in Papanicolaou-stained cervical smears 368
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 366
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 366
Nanomedicine: the future for advancing medicine and neuroscience 363
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 363
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 363
Brain targeting with polymeric nanoparticles: which administration route should we take? 361
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 360
Protein corona and nanoparticles: How can we investigate on? 356
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 350
Advances and perspectives for Central Nervous System drug delivery: the interface between nanotechnology and neuroscience 350
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 348
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 347
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 346
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
Nanoparticle formulation may affect the stabilization of an antiischemic prodrug 343
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 342
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 337
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 336
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 334
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 333
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 333
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 332
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 332
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 332
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 332
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 330
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 328
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 327
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 325
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 324
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 323
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 322
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 319
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 317
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 317
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 316
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 316
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 313
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 313
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 311
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 309
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 309
Functionalization of liposomes: microscopical methods for preformulative screening 309
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 307
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 307
Colloidal systems for CNS drug delivery 306
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 299
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 297
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 295
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 288
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 285
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 281
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 278
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 276
Brain targeting by engineered nanoparticles 275
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 273
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 272
Ketorolac tromethamine liposomes: Encapsulation and release studies 272
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 272
Totale 37.401
Salva come PNG Salva come JPEG
Categoria #
all - tutte 242.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 242.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.031 178 482 379 242 154 210 213 222 483 320 642 506
2022/20234.655 577 548 362 472 544 622 125 411 528 74 190 202
2023/20243.511 165 197 221 285 793 356 401 418 109 107 169 290
2024/202510.855 500 175 228 827 2.043 1.474 851 771 1.053 466 1.099 1.368
2025/202623.344 1.308 808 1.504 2.778 4.373 1.321 2.161 1.026 3.784 1.901 1.235 1.145
2026/2027466 466 0 0 0 0 0 0 0 0 0 0 0
Totale 65.078